期刊文献+

抗血管生成药物在乳腺癌治疗中的现状和思考 被引量:3

Status and thinking on anti-angiogenesis drugs for treatment of breast cancer
原文传递
导出
摘要 抗血管生成药物已成为肿瘤治疗的重要手段和研究热点。该类药物如贝伐单抗、舒尼替尼、索拉非尼、拉帕替尼等也被临床用于治疗乳腺癌,显示出一定疗效,同时也带来了一些问题和思考。 Anti-angiogenesis drug has become an important method and a hot research field for treating cancers. Drugs such as bevacizumab, sunitinib, sorafenib, lapatinib, achieved good clinical effect in treating breast cancers, but they also brought a lot of problems that need to be concerned.
出处 《肿瘤研究与临床》 CAS 2012年第2期73-75,83,共4页 Cancer Research and Clinic
关键词 乳腺肿瘤 血管生成抑制剂 Breast neoplasms Angiogenesis inhibitors
  • 相关文献

参考文献37

  • 1Folkman J. Tumor angiogenesis:therapeutic implications. N Engl J Med, 1971, 285: 1182-1186.
  • 2Jensen HM, Chen L, De Vamlt MR, et al. Angiogensis induced by "normal"human breast tissue:a probable marker for precancer. Science, 1982, 218: 293-295.
  • 3Weichler N, Sempk JP, Welch WR, et al. Tumor angiogensis and metastasis-correlation in invasive breast carcinoma. New Engl J Med, 1991, 324:1-8.
  • 4Guidi A J, Schmitt S J, Fischer L, ct al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis.In patients with ductal carcinoma in sitn of the breast. Cancer, 1997, 80: 1945-1953.
  • 5Veikkola T, Karkkainen M, Claesson-Welsh L, et al.Regulation of angiogensis via vascular endothelial growth factor receptors. Cancer Res, 2000, 60: 203-212.
  • 6Khosravi P, Femandez I. Tumoral angiogenesis:review of the literature. Cancer Invest, 2008, 26: 104-108.
  • 7Kerbel RS. Tumor angiogenesis. N Engl J Med, 2008, 358: 2039-2049.
  • 8Collins TS, Hurwitz HI. Targeting vascular endothelial growth factor and angiogensis for the treatment of colorectal cancer. Semlin Oncol, 2005, 32: 61-69.
  • 9Nathanson SD. Insight into the mechanisms of lymph node metastasis. Cancer, 2003, 98: 413-423.
  • 10Toi M, Bando H, Ogawa T, et al. Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor relationship in breast cancer. Int J Cancer, 2002, 98: 14-18.

同被引文献41

  • 1范钰,郑树,丁佳逸.脂质体介导的cripto反义寡核苷酸抑制结肠癌细胞端粒酶活性[J].中国病理生理杂志,2006,22(4):762-765. 被引量:42
  • 2郭辉,张玲.乳香中化学成分和药理作用的研究进展[J].食品与药品,2007,9(05A):50-52. 被引量:43
  • 3Abdel-Tawab M, Werz 0, Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet, 2011, 50: 349-369.
  • 4Zhao WZ, Entschladen F, Liu HY, et al. Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. Cancer Detect and Prev, 2003, 27: 67-75.
  • 5Hostanska K, Daum G, Sailer R. Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant nell lines in vitro. Anticancer Res, 2002, 22: 2853-2862.
  • 6Park YS, Lee JH, Harwalkar JA, et al. Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2. Adv Exp Med Biol, 2002, 507: 387-393.
  • 7Syrovets T, Gschwend JE, Buchele B, et al. Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC3 prostate cancer cells in vitro and in vivo. J Biol Chem, 2005,280: 6170-6180.
  • 8Yuan HQ, Kong F, Wang XL, et al. Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Spl binding activity in prostate cancer cells. Biochem Pharmacol, 2008, 75:2112-2121.
  • 9Liu JJ, Huang B, Hooi SC. Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells. Br J Pharmacol, 2006, 148: 1099-1107.
  • 10Kunnumakkara AB, Nair AS, Sung B, et al. Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. Mol Cancer Res, 2009, 7: 118-128.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部